Libivirumab

Libivirumab
Monoclonal antibody
Type	Whole antibody
Source	Human
Target	Hepatitis B surface antigen
Clinical data
ATC code	none;
Identifiers
CAS Number	569658-79-3 ;
ChemSpider	none;
UNII	J1R33H8X7A;
E number	{{#property:P628}}
CompTox Dashboard (EPA)	{{#property:P3117}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).;
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C6598H10232N1788O2060S46
Molar mass	149039.65 g·mol−1
	check (what is this?) (verify)

Libivirumab is a human monoclonal antibody directed against the hepatitis B virus.^[1]^[2]

References

^ WHO Drug Information
^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.